C4X Discovery Holdings plc C4XD.L Stock
C4X Discovery Holdings plc Price Chart
C4X Discovery Holdings plc C4XD.L Financial and Trading Overview
C4X Discovery Holdings plc stock price | 9 GBP |
Previous Close | 20.35 GBP |
Open | 20 GBP |
Bid | 20 GBP x 0 |
Ask | 20.5 GBP x 0 |
Day's Range | 20 - 20 GBP |
52 Week Range | 13.6 - 31 GBP |
Volume | 1.1K GBP |
Avg. Volume | 218.55K GBP |
Market Cap | 50.42M GBP |
Beta (5Y Monthly) | 0.374329 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0.04 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 48 GBP |
C4XD.L Valuation Measures
Enterprise Value | 42.25M GBP |
Trailing P/E | N/A |
Forward P/E | -0.0660066 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 11.70202 |
Price/Book (mrq) | 370.37036 |
Enterprise Value/Revenue | 9.805 |
Enterprise Value/EBITDA | -4.167 |
Trading Information
C4X Discovery Holdings plc Stock Price History
Beta (5Y Monthly) | 0.374329 |
52-Week Change | -19.047% |
S&P500 52-Week Change | 20.43% |
52 Week High | 31 GBP |
52 Week Low | 13.6 GBP |
50-Day Moving Average | 15.94 GBP |
200-Day Moving Average | 18.32 GBP |
C4XD.L Share Statistics
Avg. Volume (3 month) | 218.55K GBP |
Avg. Daily Volume (10-Days) | 414.74K GBP |
Shares Outstanding | 252.12M |
Float | 210.65M |
Short Ratio | N/A |
% Held by Insiders | 26.10% |
% Held by Institutions | 54.68% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | July 31, 2022 |
Most Recent Quarter (mrq) | January 31, 2023 |
Next Fiscal Year End | July 31, 2023 |
Profitability
Profit Margin | -174.56% |
Operating Margin (ttm) | -236.018% |
Gross Margin | 97.84% |
EBITDA Margin | -235.29% |
Management Effectiveness
Return on Assets (ttm) | -38.98% |
Return on Equity (ttm) | -52.33% |
Income Statement
Revenue (ttm) | 4.31M GBP |
Revenue Per Share (ttm) | 0.02 GBP |
Quarterly Revenue Growth (yoy) | 2439.39% |
Gross Profit (ttm) | 2.57M GBP |
EBITDA | -10139000 GBP |
Net Income Avi to Common (ttm) | -7522000 GBP |
Diluted EPS (ttm) | -0.04 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 9.64M GBP |
Total Cash Per Share (mrq) | 0.04 GBP |
Total Debt (mrq) | 587K GBP |
Total Debt/Equity (mrq) | 4.33 GBP |
Current Ratio (mrq) | 7.239 |
Book Value Per Share (mrq) | 0.054 |
Cash Flow Statement
Operating Cash Flow (ttm) | -7179000 GBP |
Levered Free Cash Flow (ttm) | -6061875 GBP |
Profile of C4X Discovery Holdings plc
Country | United Kingdom |
State | N/A |
City | Manchester |
Address | Manchester One |
ZIP | M1 3LD |
Phone | 44 1612 355 085 |
Website | https://www.c4xdiscovery.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 48 |
C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation and autoimmune diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. It has partnerships with Sanofi, therapeutics, horizon, LifeArc, INDIVIOR, and Phoremost. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. The company was incorporated in 2007 and is based in Manchester, the United Kingdom.
Q&A For C4X Discovery Holdings plc Stock
What is a current C4XD.L stock price?
C4X Discovery Holdings plc C4XD.L stock price today per share is 9 GBP.
How to purchase C4X Discovery Holdings plc stock?
You can buy C4XD.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for C4X Discovery Holdings plc?
The stock symbol or ticker of C4X Discovery Holdings plc is C4XD.L.
Which industry does the C4X Discovery Holdings plc company belong to?
The C4X Discovery Holdings plc industry is Biotechnology.
How many shares does C4X Discovery Holdings plc have in circulation?
The max supply of C4X Discovery Holdings plc shares is 2.52M.
What is C4X Discovery Holdings plc Price to Earnings Ratio (PE Ratio)?
C4X Discovery Holdings plc PE Ratio is 2.25000020 now.
What was C4X Discovery Holdings plc earnings per share over the trailing 12 months (TTM)?
C4X Discovery Holdings plc EPS is 0.04 GBP over the trailing 12 months.
Which sector does the C4X Discovery Holdings plc company belong to?
The C4X Discovery Holdings plc sector is Healthcare.